Sterling begins large-scale silica production for Nanologica

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/Anchalee Phanmaha)
(Image: Getty/Anchalee Phanmaha)

Related tags: Sterling Pharma Solutions, Chromatography, Nanologica

Sterling begins manufacturing of $14m worth of silica particles as preparative chromatography media, after deal with Chinese distributor.

UK-headquartered contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions announced the beginning of large-scale manufacture of silica particles for Swedish nanotechnology company, Nanologica.

Earlier this year, Nanologica announced the launch of its preparative chromatography media business, after an agreement to supply quantities of silica of approximately $14m (€12.6m) value to Yunbo Technology, a Chinese company.

Under the agreement, which stretches over six years (2021-2026), Yunbo will be the exclusive distributor of Nanologica’s chromatography material, known as NLAB Saga, in China.

Sterling has taken on the manufacture of the supply, following a service agreement with Nanologica in 2018​. The first batch of NLAB Saga is expected to be ready for testing in 2020 and commercially available in 2021.

Through the manufacturing collaboration, Nanologica aims to enable the provision of larger testing samples to customers and expand its customer base within preparative chromatography.

Nanologica’s switch to preparative chromatography

Nanologica had previously focused on analytical chromatography, which aims to identify compounds in liquid solutions, and conduct qualitative and quantitative analyses.

The firm has since expanded to include preparative chromatography, which aims to purify and collect desired molecules away from contaminants.

According to the company, this shift answers an increasing market demand, as ‘vastly’ greater amounts of silica are used in preparative chromatography than in analytical, offering ‘significant potential’ for growth.

Related news

Related products

show more

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Related suppliers

Follow us

Products

View more

Webinars